Olanzapine and samidorphan combination effective for long-term treatment of schizophrenia, bipolar disorder Medha Baranwal12 Jan 2024 5:00 AM ISTUSA: A phase 3, open-label extension study has shed light on the long-term safety, durability, and tolerability of olanzapine and samidorphan...
Early risers at increased risk of developing anorexia nervosa, finds JAMA study Dr. Kamal Kant Kohli9 Jan 2024 7:00 AM ISTNew research indicates that the eating disorder anorexia nervosa is associated with being an early riser, unlike many other disorders that tend to be...
Bristol Myers Squibb to acquire Karuna Therapeutics for USD 14 billion Ruchika Sharma25 Dec 2023 2:30 PM ISTPrinceton: Bristol Myers Squibb and Karuna Therapeutics, Inc. have announced that they have entered into a definitive merger agreement under...
Owning Cats And Schizophrenia, a strange link finds study Niveditha Subramani9 Dec 2023 3:58 PM ISTCats make great pets, even at small home or a big house cats are fun to live and play with however a new review suggests that having a cat as a pet...
AbbVie to focus on smaller deals after buying spree Ruchika Sharma9 Dec 2023 2:30 PM ISTAbbVie said it expects to return to "robust growth" in 2025, after its recent buying spree.
AbbVie to acquire Cerevel Therapeutics for USD 8.7 billion Ruchika Sharma8 Dec 2023 12:30 PM ISTNorth Chicago: AbbVie Inc. and Cerevel Therapeutics have announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its...
Innovative design with better resolution for functional MRI brain imaging may improve diagnosis of host of brain disorders Dr. Kamal Kant Kohli29 Nov 2023 9:45 AM ISTAn intense international effort to improve the resolution of magnetic resonance imaging (MRI) for studying the human brain has culminated in an...
Torrent Pharma gets CDSCO Panel nod to study Brexpiprazole tablet to treat schizophrenia Dr. Divya Colin26 Nov 2023 5:00 PM ISTNew Delhi: Citing that the clinical trial sites should be geographically distributed in the country, the Subject Expert Committee (SEC) functional...
Brilaroxazine improves symptoms with safety among patients with schizophrenia: Phase 3 Recover trial Dr. Kamal Kant Kohli10 Nov 2023 6:30 PM ISTUSA: A Phase 3 RECOVER trial evaluating the efficacy, safety and tolerability of once-daily brilaroxazine, a serotonin-dopamine signalling modulator...
Evenamide effects significant improvement of symptoms in resistant schizophrenia Dr. Kamal Kant Kohli29 Oct 2023 9:30 PM ISTInvestigational drug evenamide is an effective adjunct treatment for resistant schizophrenia, according to a pree release by manufacturer. It...
Gradual Antipsychotic Dose Reduction May Increase Relapse risk in Psychotic Disorders Dr Riya Dave9 Oct 2023 10:00 AM ISTA recent study led by Dr. Joanna Moncrieff from University College London suggests that reducing or discontinuing antipsychotic medication in patients...
6 medicines of Alembic Pharma received USFDA nod during Q2FY24 Ruchika Sharma4 Oct 2023 12:30 PM ISTMumbai: Alembic Pharmaceuticals Limited has announced that it has received US Food & Drug Administration (USFDA) approvals on six of its...
